Revolution Revenue Per Share from 2010 to 2025

RVMDW Stock   0.17  0.03  21.43%   
Revolution Medicines, Revenue Per Share yearly trend continues to be fairly stable with very little volatility. Revenue Per Share will likely drop to 0.11 in 2025. Revenue Per Share is the amount of revenue generated by Revolution Medicines, Warrant per share of stock, calculated by dividing total revenue by the average number of shares outstanding. View All Fundamentals
 
Revenue Per Share  
First Reported
2010-12-31
Previous Quarter
0.12
Current Value
0.11
Quarterly Volatility
0.20449012
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Revolution Medicines, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Revolution Medicines,'s main balance sheet or income statement drivers, such as Net Interest Income of 57 M, Interest Income of 57.3 M or Interest Expense of 331 K, as well as many indicators such as Price To Sales Ratio of 265, Dividend Yield of 0.0 or PTB Ratio of 1.94. Revolution financial statements analysis is a perfect complement when working with Revolution Medicines, Valuation or Volatility modules.
  
Check out the analysis of Revolution Medicines, Correlation against competitors.

Latest Revolution Medicines,'s Revenue Per Share Growth Pattern

Below is the plot of the Revenue Per Share of Revolution Medicines, Warrant over the last few years. It is the amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding. Revolution Medicines,'s Revenue Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Revolution Medicines,'s overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.00510 Years Trend
Slightly volatile
   Revenue Per Share   
       Timeline  

Revolution Revenue Per Share Regression Statistics

Arithmetic Mean0.48
Geometric Mean0.41
Coefficient Of Variation42.80
Mean Deviation0.15
Median0.55
Standard Deviation0.20
Sample Variance0.04
Range0.7458
R-Value(0.61)
Mean Square Error0.03
R-Squared0.38
Significance0.01
Slope(0.03)
Total Sum of Squares0.63

Revolution Revenue Per Share History

2025 0.11
2024 0.12
2023 0.1
2022 0.44
2021 0.4
2020 0.65
2019 0.85

About Revolution Medicines, Financial Statements

Revolution Medicines, investors use historical fundamental indicators, such as Revolution Medicines,'s Revenue Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Revolution Medicines,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Revenue Per Share 0.12  0.11 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Revolution Stock Analysis

When running Revolution Medicines,'s price analysis, check to measure Revolution Medicines,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines, is operating at the current time. Most of Revolution Medicines,'s value examination focuses on studying past and present price action to predict the probability of Revolution Medicines,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines,'s price. Additionally, you may evaluate how the addition of Revolution Medicines, to your portfolios can decrease your overall portfolio volatility.